Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masafumi Nakayama

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
Frontiers in Immunology|February 14, 2018
Macrophage Recognition of Crystals and NanoparticlesMasafumi Nakayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 24, 2007
[Coronary spastic angina and it's associated diseases]Masafumi Nakayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2004
[Vasodilatation by nitric oxide]Masafumi Nakayama
Frontiers in Immunology|January 21, 2015
Antigen Presentation by MHC-Dressed CellsMasafumi Nakayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 8, 2006
[Coronary heart disease in patients with diabetes mellitus]Masafumi Nakayama, Hisao Ogawa
Particle and Fibre Toxicology|April 13, 2017
SiO<sub>2</sub> and TiO<sub>2</sub> nanoparticles synergistically trigger macrophage inflammatory responsesMisato Tsugita, Nobuyuki Morimoto, Masafumi Nakayama
Circulation Reports|March 11, 2021
Influence of Coronary Artery Fistulae on the Diagnosis of IschemiaRyosuke Ito, Masafumi Nakayama, Nobuhiro Tanaka, et al.
Biochemical and Biophysical Research Communications|June 25, 2003
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodiesMasafumi Nakayama, Norihiro Harada, Ko Okumura, et al.
Journal of Cardiology Cases|March 11, 2020
A case report of myocardial ischemia improvement despite early bypass graft occlusion: Efficiency of physiological reassessmentMasafumi Nakayama, Takamichi Takahashi, Ryo Horinaka, et al.
Journal of Atherosclerosis and Thrombosis|August 30, 2007
Aspirin for primary prevention of atherosclerotic disease in JapanTakeshi Morimoto, Masafumi Nakayama, Yoshihiko Saito, et al.
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
Frontiers in Immunology|February 14, 2018
Macrophage Recognition of Crystals and NanoparticlesMasafumi Nakayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 24, 2007
[Coronary spastic angina and it's associated diseases]Masafumi Nakayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2004
[Vasodilatation by nitric oxide]Masafumi Nakayama
Frontiers in Immunology|January 21, 2015
Antigen Presentation by MHC-Dressed CellsMasafumi Nakayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 8, 2006
[Coronary heart disease in patients with diabetes mellitus]Masafumi Nakayama, Hisao Ogawa
Particle and Fibre Toxicology|April 13, 2017
SiO<sub>2</sub> and TiO<sub>2</sub> nanoparticles synergistically trigger macrophage inflammatory responsesMisato Tsugita, Nobuyuki Morimoto, Masafumi Nakayama
Circulation Reports|March 11, 2021
Influence of Coronary Artery Fistulae on the Diagnosis of IschemiaRyosuke Ito, Masafumi Nakayama, Nobuhiro Tanaka, et al.
Biochemical and Biophysical Research Communications|June 25, 2003
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodiesMasafumi Nakayama, Norihiro Harada, Ko Okumura, et al.
Journal of Cardiology Cases|March 11, 2020
A case report of myocardial ischemia improvement despite early bypass graft occlusion: Efficiency of physiological reassessmentMasafumi Nakayama, Takamichi Takahashi, Ryo Horinaka, et al.
Journal of Atherosclerosis and Thrombosis|August 30, 2007
Aspirin for primary prevention of atherosclerotic disease in JapanTakeshi Morimoto, Masafumi Nakayama, Yoshihiko Saito, et al.
Pageof 17